Patents Pending: The U.S. Patent System Is More Important Than Ever. It's Also a Mess. but, According to Claude Barfield and John E. Calfee, Help May Finally Be on the Way

By Barfield, Claude; Calfee, John E. | The American (Washington, DC), January-February 2008 | Go to article overview

Patents Pending: The U.S. Patent System Is More Important Than Ever. It's Also a Mess. but, According to Claude Barfield and John E. Calfee, Help May Finally Be on the Way


Barfield, Claude, Calfee, John E., The American (Washington, DC)


[ILLUSTRATION OMITTED]

Q Are patents important?

A More than ever. The Founders did the right thing when they inserted patent protection directly into the Constitution (Article I, Section 8). A substantial fraction of the value of U. S. firms--on the order of 30 percent--consists of so-called intangible property, much of which comprises patents, along with copyrights and trademarks. Patents are particularly important in the pharmaceutical and biotech industries. A small number of patents--sometimes, just one--can provide the foundation for years of research and development before a drug is ready for Food & Drug Administration approval and public use. For the most part, the FDA requirements make it impossible to keep these inventions secret; patents protect drug developers from having their inventions poached by competitors. If pharmaceutical patents didn't exist, most of the best drugs of the past half-century or so might never have been developed.

[FIGURE 1 OMITTED]

Q Is the patent system in a mess?

A Yes, but there are encouraging signs of improvement. Five or ten years ago, the situation was bleak. Patent and Trademark Office (PTO) examiners faced incentives to grant all sorts of questionable patents, were overworked in the face of sweeping new technologies, were losing much of their user-fee revenues to other government operations, and sometimes found the courts opposed to common-sense limits on patents. There was talk of impending disaster.

Q So what happened?

A Self-correcting forces prevailed. Users of high-tech patents have formed complex but nonetheless workable licensing pools. The PTO has reined in some of the stranger patenting offshoots such as business-methods patents (the notion of patenting a way of doing something, like recording an online sales transaction) and excessively broad patents for stem cells and other innovations. The Court of Appeals for the Federal Circuit, which handles all the patent cases that are appealed from District Court opinions, has been favoring plaintiffs in infringement suits only 40 percent of the time, compared with 60 percent earlier. The Court of Appeals has also been beefing up the traditional "written description" requirement (the notion that the inventor has to describe the invention clearly) in order to overturn especially far-reaching patents held by the University of California and the University of Rochester. And in its KSR International v. Teleflex decision, the Supreme Court made clear that it will demand more in the way of novelty for some patented inventions. In the meantime, research institutions in academia have found ways to deal with a vast array of other people's science-based patents while still getting research done.

Q What were those academics worried about?

A Universities are doing a lot of patenting. The University of California alone has pulled in $500 million in license fees in the past five years while vigorously defending its patent portfolio. But many academics and people in high-tech industries have worried about "patent thickets" that would make a lot of clever research impossible unless researchers managed to track down scores of patent holders to negotiate licensing deals. The result would be an "anticommons," in which too much diversified ownership of intellectual property would impede R&D investment--just the opposite of the "tragedy of the commons," in which nobody invests in a commons area because no one owns it. Fortunately, that hasn't happened. Academic research continues to flourish even as patents multiply like biotech mice, and the patent system does not seem to get very much in the way.

Q So what problems remain?

A For one thing, many patents are still in force that should not have been granted in the first place. But there are also some serious problems in how the patent system works, both before and after patents are granted. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Patents Pending: The U.S. Patent System Is More Important Than Ever. It's Also a Mess. but, According to Claude Barfield and John E. Calfee, Help May Finally Be on the Way
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.